The therapy performs by blocking the action of Bruton’s tyrosine kinase (BTK), an enzyme critical with the activation of B-cells and microglia �?immune cells that generate the inflammation that damages the anxious process in MS. Change in whole serum concentrations of immunoglobulin subclasses in the cure period in Cohort 1. https://peterj307ydi0.wikififfi.com/user